$MCVT
Mill City Ventures III, Ltd Stock $mcvt

$mcvt Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000165495423007056 Filed on May 22, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q4
Revenue	$337.5K	-$1.026M	$847.5K
YoY Change	-54.04%	-325.75%	24.96%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$530.0K	$1.855M	$499.8K
YoY Change	16.62%	287.39%	50.91%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$570.0K	$1.890M	$499.8K
YoY Change	13.5%	246.23%	50.91%
Operating Profit		$168.0K
YoY Change
Interest Expense	$43.33K	$34.67K	-$832.0K
YoY Change	-9.33%	-48.21%	2662.12%
% of Operating Profit		20.64%
Other Income/Expense, Net
YoY Change
Pretax Income	$360.0K	-$977.3K	-$484.2K
YoY Change	-50.97%	-271.13%	-252.78%
Income Tax	$287.0K	-$259.3K	-$167.9K
% Of Pretax Income	79.72%
Net Earnings	$70.00K	-$718.0K	-$316.3K
YoY Change	-86.49%	-274.24%	-215.76%
Net Earnings / Revenue	20.74%		-37.32%
Basic Earnings Per Share	$0.01	-$0.12
Diluted Earnings Per Share	$0.01	-$0.12	-$0.05
COMMON SHARES
Basic Shares Outstanding	6.185M shares	6.185M shares	6.185M shares
Diluted Shares Outstanding		6.185M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.100M	$439.8K	$1.090M
YoY Change	74.72%	519.3%	-43.72%
Cash & Equivalents	$1.102M	$439.8K	$1.090M
Short-Term Investments
Other Short-Term Assets	$160.0K	$267.6K	$49.22K
YoY Change	19.75%	802.12%	-41.17%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.820M	$1.324M	$1.640M
YoY Change	25.29%	44.89%	-36.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.00K	$10.90K	$16.40K
YoY Change	-62.69%		229.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.290M	$1.419M	$1.423M
YoY Change	763.92%	-29.47%	-41.91%
Other Assets	$430.0K	$461.0K	$201.0K
YoY Change
Total Long-Term Assets	$16.96M	$20.18M	$16.93M
YoY Change	10.37%	0.48%	20.01%
TOTAL ASSETS
Total Short-Term Assets	$1.820M	$1.324M	$1.640M
Total Long-Term Assets	$16.96M	$20.18M	$16.93M
Total Assets	$18.78M	$21.51M	$18.57M
YoY Change	11.66%	2.41%	11.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$80.00K	$91.04K	$136.5K
YoY Change	54.49%	-13.22%	113.2%
Accrued Expenses	$10.00K	$11.07K	$16.56K
YoY Change	-95.62%	-99.23%	-98.7%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$90.00K	$102.1K	$153.1K
YoY Change	-67.84%	-93.37%	-95.27%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$2.750M	$0.00
YoY Change	-100.0%	-48.36%
Other Long-Term Liabilities	$10.00K	$42.22K	$70.15K
YoY Change		-84.48%
Total Long-Term Liabilities	$10.00K	$2.792M	$70.15K
YoY Change	-99.52%	-50.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$90.00K	$102.1K	$153.1K
Total Long-Term Liabilities	$10.00K	$2.792M	$70.15K
Total Liabilities	$97.13K	$2.894M	$223.2K
YoY Change	-95.94%	-59.66%	-93.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.160M	-$1.160M	-$1.160M
YoY Change	0.0%	0.0%	0.0%
Common Stock	$1.472M	$1.472M	$12.22K
YoY Change	13464.48%	13546.19%	13.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$18.68M	$18.61M	$18.34M
YoY Change
Total Liabilities & Shareholders Equity	$18.78M	$21.51M	$18.57M
YoY Change	11.66%	2.41%	11.19%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q4
OPERATING ACTIVITIES
Net Income	$70.00K	-$718.0K	-$316.3K
YoY Change	-86.49%	-274.24%	-215.76%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$3.410M	-$3.400M	$1.541M
YoY Change	-10.46%	-52.72%	-366.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.750M	$2.750M	-2.313M
YoY Change	-15.38%	-48.36%	114.36%
NET CHANGE
Cash From Operating Activities	3.410M	-$3.400M	1.541M
Cash From Investing Activities
Cash From Financing Activities	-2.750M	$2.750M	-2.313M
Net Change In Cash	660.0K	-$649.8K	-772.0K
YoY Change	18.16%	-65.16%	-53.45%
FREE CASH FLOW
Cash From Operating Activities	$3.410M	-$3.400M	$1.541M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001425355
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	111111111	shares
CY2022Q4	us-gaap	Common Stock Held By Subsidiary CommonStockHeldBySubsidiary	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.00
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.00
CY2022Q4	mcvt	Operating Leases Liability OperatingLeasesLiability	0	usd
CY2022Q4	mcvt	Less Short Term Portion LessShortTermPortion	0	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023Q1	mcvt	Operating Lease Weighted Average Remaining Lease Term OperatingLeaseWeightedAverageRemainingLeaseTerm	P1Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045	pure
CY2022Q1	mcvt	Investment Company Provision For Income Taxes Per Share InvestmentCompanyProvisionForIncomeTaxesPerShare	-0.02
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1793739	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6185255	shares
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-41472
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	MILL CITY VENTURES III, LTD.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0316651
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1907 Wayzata Blvd
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	#205
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Wayzata
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55391
CY2023Q1	dei	City Area Code CityAreaCode	952
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	479-1923
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6185255	shares
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	19712356	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	16708432	usd
CY2023Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	19715304	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	17359804	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	439829	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1089641	usd
CY2023Q1	us-gaap	Notes Receivable Net NotesReceivableNet	250000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	250000	usd
CY2023Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	267568	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	218440	usd
CY2023Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	366391	usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	250879	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10903	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16398	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	461000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	201000	usd
CY2023Q1	us-gaap	Assets Assets	21508047	usd
CY2022Q4	us-gaap	Assets Assets	18734790	usd
CY2023Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	91038	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	776514	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	2750000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	11067	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	16562	usd
CY2023Q1	us-gaap	Deferred Income DeferredIncome	42217	usd
CY2022Q4	us-gaap	Deferred Income DeferredIncome	70154	usd
CY2023Q1	us-gaap	Liabilities Liabilities	2894322	usd
CY2022Q4	us-gaap	Liabilities Liabilities	863230	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	111111111	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6185255	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	12215	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	12215	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15043291	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15043291	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1460209	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	0	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1159665	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1159665	usd
CY2023Q1	mcvt	Accumulated Undistributed Investment Loss AccumulatedUndistributedInvestmentLoss	-1853206	usd
CY2022Q4	mcvt	Accumulated Undistributed Investment Loss AccumulatedUndistributedInvestmentLoss	-1086739	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	5113829	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	5713829	usd
CY2023Q1	mcvt	Net Unrealized Appreciation Depreciation In Value Of Investments NetUnrealizedAppreciationDepreciationInValueOfInvestments	-2948	usd
CY2022Q4	mcvt	Net Unrealized Appreciation Depreciation In Value Of Investments NetUnrealizedAppreciationDepreciationInValueOfInvestments	-651371	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	18613725	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17871560	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21508047	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18734790	usd
CY2023Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	3.01
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.89
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	864028	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1000206	usd
CY2023Q1	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	864028	usd
CY2022Q1	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	1000206	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	129851	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	198518	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1130439	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	196442	usd
CY2023Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	27000	usd
CY2022Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	30097	usd
CY2023Q1	us-gaap	Occupancy Net OccupancyNet	19043	usd
CY2022Q1	us-gaap	Occupancy Net OccupancyNet	16812	usd
CY2023Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	532968	usd
CY2022Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	30000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	34667	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	66939	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	15827	usd
CY2022Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	7010	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1889795	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	545818	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	-1025767	usd
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	454388	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-600000	usd
CY2022Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	138770	usd
CY2023Q1	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	648423	usd
CY2022Q1	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	-22047	usd
CY2023Q1	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	48423	usd
CY2022Q1	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	116723	usd
CY2023Q1	mcvt	Investment Company Net Assets From Operations Increase Decrease Net Of Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseNetOfTax	-977344	usd
CY2022Q1	mcvt	Investment Company Net Assets From Operations Increase Decrease Net Of Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseNetOfTax	571111	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-259300	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	159000	usd
CY2023Q1	mcvt	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	-718044	usd
CY2022Q1	mcvt	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	412111	usd
CY2023Q1	mcvt	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.12
CY2022Q1	mcvt	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	0.09
CY2023Q1	mcvt	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	6185255	shares
CY2022Q1	mcvt	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	4795739	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17871560	usd
CY2023Q1	mcvt	Issuance Of Stock Options IssuanceOfStockOptions	1460209	usd
CY2023Q1	mcvt	Net Investment Loss Net Of Tax Benefit Of259300 NetInvestmentLossNetOfTaxBenefitOf259300	-766467	usd
CY2023Q1	mcvt	Net Realized Loss On Investment Transactions NetRealizedLossOnInvestmentTransactions	-600000	usd
CY2023Q1	mcvt	Appreciation In Value Of Investments AppreciationInValueOfInvestments	648423	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	18613725	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13414049	usd
CY2022Q1	mcvt	Net Investment Gain Net Of Tax Of159000 NetInvestmentGainNetOfTaxOf159000	295388	usd
CY2022Q1	mcvt	Net Realized Gain On Investment Transactions NetRealizedGainOnInvestmentTransactions	138770	usd
CY2022Q1	mcvt	Depreciation In Value Of Investments DepreciationInValueOfInvestments	-22047	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	13826160	usd
CY2023Q1	mcvt	Net Increase In Net Assets Resulting From Operations NetIncreaseInNetAssetsResultingFromOperations	-718044	usd
CY2022Q1	mcvt	Net Increase In Net Assets Resulting From Operations NetIncreaseInNetAssetsResultingFromOperations	412111	usd
CY2023Q1	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	648423	usd
CY2022Q1	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	-22047	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-600000	usd
CY2022Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	138770	usd
CY2023Q1	mcvt	Purchases Of Investments PurchasesOfInvestments	-6900500	usd
CY2022Q1	mcvt	Purchases Of Investments PurchasesOfInvestments	-7025000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	3945000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1152898	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1460209	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-260000	usd
CY2022Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-6000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-43633	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	59000	usd
CY2023Q1	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-115512	usd
CY2022Q1	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-238643	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-690971	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	35229	usd
CY2023Q1	us-gaap	Noninterest Income NoninterestIncome	27938	usd
CY2022Q1	us-gaap	Noninterest Income NoninterestIncome	272000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	165000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	0	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1900000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3399812	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7190128	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2750000	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	5325000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2750000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5325000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-649812	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1865128	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1089641	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1936148	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	439829	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71020	usd
CY2023Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	19715304	usd
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	19712356	usd
CY2023Q1	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	1.0746	pure
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	439829	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	439829	usd
CY2023Q1	mcvt	Cash And Cash Equivalents Percent Of Net Assets CashAndCashEquivalentsPercentOfNetAssets	0.0240	pure
CY2023Q1	mcvt	Investments And Cash Cost InvestmentsAndCashCost	20155133	usd
CY2023Q1	mcvt	Investments And Cash Fair Value InvestmentsAndCashFairValue	20152185	usd
CY2023Q1	mcvt	Investments And Cash Percentage Of Net Assets InvestmentsAndCashPercentageOfNetAssets	1.0986	pure
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	17359804	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	16708432	usd
CY2022	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.9350	pure
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1089641	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1089641	usd
CY2022	mcvt	Cash And Cash Equivalents Percent Of Net Assets CashAndCashEquivalentsPercentOfNetAssets	0.0610	pure
CY2022Q4	mcvt	Investments And Cash Cost InvestmentsAndCashCost	18449445	usd
CY2022Q4	mcvt	Investments And Cash Fair Value InvestmentsAndCashFairValue	17798073	usd
CY2022	mcvt	Investments And Cash Percentage Of Net Assets InvestmentsAndCashPercentageOfNetAssets	0.9960	pure
CY2023Q1	srt	Taxable Investment Securities Average Yield TaxableInvestmentSecuritiesAverageYield	0.40	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	0	usd
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	18164	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	11226	usd
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	14859	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11226	usd
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	33023	usd
CY2023Q1	mcvt	Operating Lease Interest OperatingLeaseInterest	-159	usd
CY2022Q1	mcvt	Operating Lease Interest OperatingLeaseInterest	-1035	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	11067	usd
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	31988	usd
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.89
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.79
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;font-family:times new roman;margin:0px"><strong><em>Use of estimates: </em></strong>The preparation of financial statements in conformity with GAAP requires management and our independent board members to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. For more information, see the “Valuation of portfolio investments” caption below, and “Note 4 – Fair Value of Financial Instruments” below. The Company presents its financial statements as an investment company following accounting and reporting guidance in ASC 946.</p>
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	461000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	201000	usd
CY2023Q1	us-gaap	Prepaid Taxes PrepaidTaxes	178600	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	179300	usd
CY2023Q1	us-gaap	Dividend Income Securities Operating Taxable DividendIncomeSecuritiesOperatingTaxable	259300	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.26	pure
CY2022Q1	us-gaap	Dividend Income Securities Operating Taxable DividendIncomeSecuritiesOperatingTaxable	159000	usd
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.28	pure
CY2023Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	19715304	usd
CY2023Q1	mcvt	Investment And Loan Percentage Of Fair Value InvestmentAndLoanPercentageOfFairValue	1.000	pure
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	19712356	usd
CY2023Q1	mcvt	Investment And Loans Amortized Cost InvestmentAndLoansAmortizedCost	1.000	pure
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	17359804	usd
CY2022	mcvt	Investment And Loans Amortized Cost InvestmentAndLoansAmortizedCost	1.000	pure
CY2022	mcvt	Investment And Loan Percentage Of Fair Value InvestmentAndLoanPercentageOfFairValue	1.000	pure
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	19712356	usd
CY2023Q1	mcvt	Investment And Loan Percentage Of Fair Value InvestmentAndLoanPercentageOfFairValue	1.000	pure
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	16708432	usd
CY2022	mcvt	Investment And Loan Percentage Of Fair Value InvestmentAndLoanPercentageOfFairValue	1.000	pure
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	168000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Leased Assets Net Operating Leases GainLossOnSaleOfLeasedAssetsNetOperatingLeases	168000	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	100000	usd
CY2020Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.43
CY2019Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.05
CY2023Q1	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	18293034	usd
CY2023Q1	mcvt	Preferred Stock PreferredStock	1200000	usd
CY2023Q1	us-gaap	Common Stock Held By Subsidiary CommonStockHeldBySubsidiary	209322	usd
CY2023Q1	mcvt	Fair Value Other Equity FairValueOtherEquity	10000	usd
CY2023Q1	mcvt	Fair Value Total Equity FairValueTotalEquity	19712356	usd
CY2022Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	15285932	usd
CY2022Q4	mcvt	Preferred Stock PreferredStock	1200000	usd
CY2022Q4	mcvt	Fair Value Other Equity FairValueOtherEquity	222500	usd
CY2022Q4	mcvt	Fair Value Total Equity FairValueTotalEquity	16708432	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	2750000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023Q1	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2027-01-03
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	870000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.11
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	870000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.11
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	870000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.11
CY2023Q1	mcvt	Weighted Average Grant Date Fair Value For Options Granted During The Period WeightedAverageGrantDateFairValueForOptionsGrantedDuringThePeriod	1242902	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0348	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.9000	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10903	usd
CY2023Q1	mcvt	Operating Leases Liability OperatingLeasesLiability	11067	usd
CY2023Q1	mcvt	Less Short Term Portion LessShortTermPortion	-11067	usd
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6185255	shares
CY2022Q3	mcvt	Stockholders Equity Reverse Stock StockholdersEquityReverseStock	common shares on a 1-for-2.25 basis such that every 2.25 shares of common stock
CY2022Q3	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	111111111	shares
CY2023Q1	mcvt	Investment Company Net Increase Decrease In Net Assets From Operations InvestmentCompanyNetIncreaseDecreaseInNetAssetsFromOperations	-718044	usd
CY2022Q1	mcvt	Investment Company Net Increase Decrease In Net Assets From Operations InvestmentCompanyNetIncreaseDecreaseInNetAssetsFromOperations	412111	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6185255	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4795739	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045	pure
CY2023Q1	mcvt	Rent Expense RentExpense	19043	usd
CY2021	mcvt	Rent Expense RentExpense	16812	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	5504	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	4779	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	4905	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	4601	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	8634	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	7432	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	19043	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	16812	usd
CY2018Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.30
CY2023Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	-0.17
CY2022Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.09
CY2021Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.00
CY2020Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.00
CY2019Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	-0.05
CY2023Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.01
CY2021Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.50
CY2020Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.07
CY2019Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.27
CY2023Q1	mcvt	Investment Company Provision For Income Taxes Per Share InvestmentCompanyProvisionForIncomeTaxesPerShare	0.04
CY2022Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.02
CY2021Q1	mcvt	Investment Company Provision For Income Taxes Per Share InvestmentCompanyProvisionForIncomeTaxesPerShare	-0.14
CY2020Q1	mcvt	Investment Company Provision For Income Taxes Per Share InvestmentCompanyProvisionForIncomeTaxesPerShare	0.00
CY2019Q1	mcvt	Investment Company Provision For Income Taxes Per Share InvestmentCompanyProvisionForIncomeTaxesPerShare	0.00
CY2023Q1	mcvt	Investmentcompanyissuance Of Stock Options InvestmentcompanyissuanceOfStockOptions	0.24
CY2022Q1	mcvt	Investmentcompanyissuance Of Stock Options InvestmentcompanyissuanceOfStockOptions	0.00
CY2021Q1	mcvt	Investmentcompanyissuance Of Stock Options InvestmentcompanyissuanceOfStockOptions	0.00
CY2020Q1	mcvt	Investmentcompanyissuance Of Stock Options InvestmentcompanyissuanceOfStockOptions	0.00
CY2019Q1	mcvt	Investmentcompanyissuance Of Stock Options InvestmentcompanyissuanceOfStockOptions	0.00
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.00
CY2021Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.00
CY2020Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.00
CY2019Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.00
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.00
CY2022Q1	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.00
CY2021Q1	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.00
CY2020Q1	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.00
CY2023Q1	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.00
CY2019Q1	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.11
CY2023Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	3.01
CY2022Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.88
CY2021Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.79
CY2020Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	1.98
CY2019Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.41
CY2023Q1	mcvt	Market Value Of Investments Per Share MarketValueOfInvestmentsPerShare	3.19
CY2022Q1	mcvt	Market Value Of Investments Per Share MarketValueOfInvestmentsPerShare	4.19
CY2021Q1	mcvt	Market Value Of Investments Per Share MarketValueOfInvestmentsPerShare	2.81
CY2020Q1	mcvt	Market Value Of Investments Per Share MarketValueOfInvestmentsPerShare	0.92
CY2019Q1	mcvt	Market Value Of Investments Per Share MarketValueOfInvestmentsPerShare	1.76
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6185255	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4795739	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4794184	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4918845	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4918845	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6185255	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4795739	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4918845	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4918845	shares
CY2023Q1	mcvt	Net Assets At End Of Period NetAssetsAtEndOfPeriod	18613725	usd
CY2022Q1	mcvt	Net Assets At End Of Period NetAssetsAtEndOfPeriod	13826160	usd
CY2021Q1	mcvt	Net Assets At End Of Period NetAssetsAtEndOfPeriod	13391679	usd
CY2020Q1	mcvt	Net Assets At End Of Period NetAssetsAtEndOfPeriod	9786615	usd
CY2019Q1	mcvt	Net Assets At End Of Period NetAssetsAtEndOfPeriod	11890188	usd
CY2023Q1	mcvt	Average Net Assets AverageNetAssets	18242642	usd
CY2022Q1	mcvt	Average Net Assets AverageNetAssets	13620104	usd
CY2021Q1	mcvt	Average Net Assets AverageNetAssets	12516283	usd
CY2020Q1	mcvt	Average Net Assets AverageNetAssets	9927574	usd
CY2019Q1	mcvt	Average Net Assets AverageNetAssets	12911895	usd
CY2023Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.0415	pure
CY2022Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0323	pure
CY2021Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.1481	pure
CY2020Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.0330	pure
CY2019Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0490	pure
CY2023Q1	mcvt	Investment Company Portfolio Turnover Rate InvestmentCompanyPortfolioTurnoverRate	0.2163	pure
CY2022Q1	mcvt	Investment Company Portfolio Turnover Rate InvestmentCompanyPortfolioTurnoverRate	0.0846	pure
CY2021Q1	mcvt	Investment Company Portfolio Turnover Rate InvestmentCompanyPortfolioTurnoverRate	0.4024	pure
CY2020Q1	mcvt	Investment Company Portfolio Turnover Rate InvestmentCompanyPortfolioTurnoverRate	0.0075	pure
CY2019Q1	mcvt	Investment Company Portfolio Turnover Rate InvestmentCompanyPortfolioTurnoverRate	0.0093	pure
CY2023Q1	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.3582	pure
CY2022Q1	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.1528	pure
CY2021Q1	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.1620	pure
CY2020Q1	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.0782	pure
CY2019Q1	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.0606	pure
CY2023Q1	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	-0.2092	pure
CY2022Q1	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.1424	pure
CY2021Q1	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0042	pure
CY2020Q1	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0087	pure
CY2019Q1	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	-0.0487	pure
CY2023Q1	mcvt	Investment Company Realized Gains Losses Ratio InvestmentCompanyRealizedGainsLossesRatio	0.1268	pure
CY2022Q1	mcvt	Investment Company Realized Gains Losses Ratio InvestmentCompanyRealizedGainsLossesRatio	0.0420	pure
CY2021Q1	mcvt	Investment Company Realized Gains Losses Ratio InvestmentCompanyRealizedGainsLossesRatio	1.3332	pure
CY2020Q1	mcvt	Investment Company Realized Gains Losses Ratio InvestmentCompanyRealizedGainsLossesRatio	0.0100	pure
CY2019Q1	mcvt	Investment Company Realized Gains Losses Ratio InvestmentCompanyRealizedGainsLossesRatio	1.3757	pure

Files In Submission

Name	View Source	Status
0001654954-23-007056-index-headers.html	Edgar Link	pending
0001654954-23-007056-index.html	Edgar Link	pending
0001654954-23-007056.txt	Edgar Link	pending
0001654954-23-007056-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
mcvt-20230331.xsd	Edgar Link	pending
mcvt_10q.htm	Edgar Link	pending
mcvt_ex311.htm	Edgar Link	pending
mcvt_ex312.htm	Edgar Link	pending
mcvt_ex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
mcvt-20230331_cal.xml	Edgar Link	unprocessable
mcvt-20230331_pre.xml	Edgar Link	unprocessable
mcvt_10q_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mcvt-20230331_lab.xml	Edgar Link	unprocessable
mcvt-20230331_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MCVT
Mill City Ventures III, Ltd Stock $mcvt

2023 Q2 Form 10-Q Financial Statement

#000165495423007056 Filed on May 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MCVT Mill City Ventures III, Ltd Stock $mcvt

2023 Q2 Form 10-Q Financial Statement

#000165495423007056 Filed on May 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MCVT
Mill City Ventures III, Ltd Stock $mcvt